tofisopam has been researched along with Coronary Disease in 1 studies
tofisopam: structure; dextofisopam is the R-enantiomer of tofisopam & antidiarrheal
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vanchakova, NP | 1 |
| Popov, AP | 1 |
1 trial available for tofisopam and Coronary Disease
| Article | Year |
|---|---|
Tenoten in the therapy of anxious disturbances in patients with essential hypertension and coronary heart disease.
Topics: Adult; Anti-Anxiety Agents; Antibodies; Antihypertensive Agents; Anxiety; Benzodiazepines; Coronary | 2009 |